Press Releases

INDIANAPOLIS, Nov. 4, 2019 /PRNewswire/ -- MiraVista Diagnostics, a global leader in diagnostic testing for fungal diseases, has advanced unprecedented growth in 2019. The company's recent expansion efforts include a 27 percent growth in workforce, construction of 24,000 square feet of research and development space, expansion of molecular diagnostic capabilities an

Paul Campanelli Appointed Chairman of the Board, Will Also Continue as President and Chief Executive Officer Until Successor Appointed; Roger Kimmel Appointed Senior Independent Director DUBLIN, Nov. 4, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that Paul V. Campanelli, President and Chi

- Operating Performance Led by Year-over-Year Double-Digit-Percentage Revenue Growth in Sterile Injectables and in Specialty Products Portfolio of Branded Pharmaceuticals -- Full-Year 2019 Financial Guidance Updated to Narrow Expected Ranges for Revenue, Adjusted Diluted Net Income per Share from Continuing Operations and Adjusted EBITDA - DUBLIN, Nov. 4, 2019 /PRNewswir

SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter ended September 30, 2019.Recent Corporate Updates:Presented early clinical data from the Phase1/2 trial of MRTX849 on

INDIANAPOLIS, Nov. 4, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Credit Suisse 28th Annual Healthcare Conference on Wednesday, November 13, 2019. Anne White, president of Lilly Oncology, Kimberly Blackwell, M.D., vice president, early phase clinical research,

IRVINE, Calif., Nov. 4, 2019 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: HCP, to become "PEAK" effective November 5, 2019) ("Healthpeak") announced today that it has commenced a public offering of an aggregate of 15,000,000 shares of its common stock in connection with the forward sale agreement described below.  The underwriters are expected to be

ROCKVILLE, Md., Nov. 4, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop th

CUPERTINO, Calif., Nov. 4, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended September 30, 2019 and

SEATTLE, Nov. 4, 2019 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the third quarter and nine months ended September 30, 2019."We advanced our pacritinib development program in the third quarter, and recently took an important step forward for the company by initiating and enrolli

GERMANTOWN, Md., Nov. 4, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the